Postpolio Syndrome Follow-up

1. Lo JK, Robinson LR. Postpolio syndrome and the late effects of poliomyelitis. Part 1. pathogenesis, biomechanical considerations, diagnosis, and investigations. Muscle Nerve. 2018 Dec. 58 (6):751-9. [QxMD MEDLINE Link]. [Full Text].

2. Lo JK, Robinson LR. Post-polio syndrome and the late effects of poliomyelitis: Part 2. treatment, management, and prognosis. Muscle Nerve. 2018 Dec. 58 (6):760-9. [QxMD MEDLINE Link]. [Full Text].

3. Halstead LS. Assessment and differential diagnosis for post-polio syndrome. Orthopedics. 1991 Nov. 14(11):1209-17. [QxMD MEDLINE Link].

4. Polio Australia Inc. The Late Effects of Polio: Introduction to Clinical Practice. Available at http://www.postpolio.org.nz/__data/assets/pdf_file/0016/56050/The-Late-Effects-of-Polio-Introduction-to-Clinical-Practice.pdf. 2012; Accessed: August 14, 2017.

5. March of Dimes Birth Defects Foundation. Post-polio syndrome: identifying best practices in diagnosis and care. http://www.marchofdimes.com/mission/polio.aspx. Available at http://www.polioplace.org/sites/default/files/files/MOD-%20Identifying.pdf. Accessed: Aug 11, 2017.

6. Correa JC, Rocco CC, de Andrade DV, et al. Electromyographic and neuromuscular analysis in patients with post-polio syndrome. Electromyogr Clin Neurophysiol. 2008 Nov-Dec. 48(8):329-33. [QxMD MEDLINE Link].

7. Tersteeg IM, Koopman FS, Stolwijk-Swuste JM, Beelen A, Nollet F. A 5-year longitudinal study of fatigue in patients with late-onset sequelae of poliomyelitis. Arch Phys Med Rehabil. 2011 Jun. 92(6):899-904. [QxMD MEDLINE Link].

8. Atwal A, Giles A, Spiliotopoulou G, Plastow N, Wilson L. Living with polio and postpolio syndrome in the United Kingdom. Scand J Caring Sci. 2013 Jun. 27(2):238-45. [QxMD MEDLINE Link].

9. Duncan A, Batliwalla Z. Growing older with post-polio syndrome: social and quality-of-life implications. SAGE Open Med. 2018. 6:2050312118793563. [QxMD MEDLINE Link]. [Full Text].

10. Gonzalez H, Ottervald J, Nilsson KC, et al. Identification of novel candidate protein biomarkers for the post-polio syndrome - implications for diagnosis, neurodegeneration and neuroinflammation. J Proteomics. 2009 Jan 30. 71(6):670-81. [QxMD MEDLINE Link].

11. Bouza C, Munoz A, Amate JM. Postpolio syndrome: a challenge to the health-care system. Health Policy. 2005 Jan. 71(1):97-106. [QxMD MEDLINE Link].

12. Wendebourg MJ, Weigel M, Richter L, et al. Spinal cord gray matter atrophy is associated with functional decline in post-polio syndrome. Eur J Neurol. 2022 May. 29 (5):1435-45. [QxMD MEDLINE Link]. [Full Text].

13. Li Hi Shing S, Lope J, Chipika RH, Hardiman O, Bede P. Extra-motor manifestations in post-polio syndrome (PPS): fatigue, cognitive symptoms and radiological features. Neurol Sci. 2021 Feb 26. [QxMD MEDLINE Link].

14. Ramlow J, Alexander M, LaPorte R, Kaufmann C, Kuller L. Epidemiology of the post-polio syndrome. Am J Epidemiol. 1992 Oct 1. 136(7):769-86. [QxMD MEDLINE Link].

15. Quadros AA, Conde MT, Marin LF, Silva HC, Silva TM, Paula MB, et al. Frequency and clinical manifestations of post-poliomyelitis syndrome in a Brazilian tertiary care center. Arq Neuropsiquiatr. 2012 Aug. 70(8):571-3. [QxMD MEDLINE Link].

16. Ragonese P, Fierro B, Salemi G, Randisi G, Buffa D, D'Amelio M, et al. Prevalence and risk factors of post-polio syndrome in a cohort of polio survivors. J Neurol Sci. 2005 Sep 15. 236(1-2):31-5. [QxMD MEDLINE Link].

17. Bertolasi L, Acler M, dall'Ora E, Gajofatto A, Frasson E, Tocco P, et al. Risk factors for post-polio syndrome among an Italian population: a case-control study. Neurol Sci. 2012 Dec. 33(6):1271-5. [QxMD MEDLINE Link].

18. Thakral M, Lacroix AZ, Molton IR. Sex/gender disparities in health outcomes of individuals with long-term disabling conditions. Rehabil Psychol. 2019 May. 64 (2):221-8. [QxMD MEDLINE Link].

19. Berlly MH, Strauser WW, Hall KM. Fatigue in postpolio syndrome. Arch Phys Med Rehabil. 1991 Feb. 72(2):115-8. [QxMD MEDLINE Link].

20. McNalley TE, Yorkston KM, Jensen MP, et al. Review of secondary health conditions in postpolio syndrome: prevalence and effects of aging. Am J Phys Med Rehabil. 2015 Feb. 94 (2):139-45. [QxMD MEDLINE Link]. [Full Text].

21. Trojan DA, Arnold DL, Shapiro S, Bar-Or A, Robinson A, Le Cruguel JP, et al. Fatigue in post-poliomyelitis syndrome: association with disease-related, behavioral, and psychosocial factors. PM R. 2009 May. 1(5):442-9. [QxMD MEDLINE Link].

22. Romigi A, Pierantozzi M, Placidi F, et al. Restless legs syndrome and post polio syndrome: a case-control study. Eur J Neurol. 2015 Mar. 22 (3):472-8. [QxMD MEDLINE Link].

23. Trojan DA, Cashman NR. Post-poliomyelitis syndrome. Muscle Nerve. 2005 Jan. 31(1):6-19. [QxMD MEDLINE Link].

24. Bickerstaffe A, Beelen A, Nollet F. Change in physical mobility over 10 years in post-polio syndrome. Neuromuscul Disord. 2015 Mar. 25 (3):225-30. [QxMD MEDLINE Link].

25. Klein MG, Whyte J, Keenan MA, Esquenazi A, Polansky M. Changes in strength over time among polio survivors. Arch Phys Med Rehabil. 2000 Aug. 81(8):1059-64. [QxMD MEDLINE Link].

26. Stolwijk-Swüste JM, Beelen A, Lankhorst GJ, Nollet F. The course of functional status and muscle strength in patients with late-onset sequelae of poliomyelitis: a systematic review. Arch Phys Med Rehabil. 2005 Aug. 86(8):1693-701. [QxMD MEDLINE Link].

27. Fordyce CB, Gagne D, Jalili F, et al. Elevated serum inflammatory markers in post-poliomyelitis syndrome. J Neurol Sci. 2008 Aug 15. 271(1-2):80-6. [QxMD MEDLINE Link].

28. Stoelb BL, Carter GT, Abresch RT, et al. Pain in persons with postpolio syndrome: frequency, intensity, and impact. Arch Phys Med Rehabil. 2008 Oct. 89(10):1933-40. [QxMD MEDLINE Link].

29. Werhagen L, Borg K. Impact of pain on quality of life in patients with post-polio syndrome. J Rehabil Med. 2013 Feb. 45(2):161-3. [QxMD MEDLINE Link].

30. Portnoy S, Schwartz I. Gait characteristics of post-poliomyelitis patients: Standardization of quantitative data reporting. Ann Phys Rehabil Med. 2013 Oct. 56(7-8):527-41. [QxMD MEDLINE Link].

31. Vreede KS, Henriksson J, Borg K, Henriksson M. Gait characteristics and influence of fatigue during the 6-minute walk test in patients with post-polio syndrome. J Rehabil Med. 2013 Sep. 45(9):924-8. [QxMD MEDLINE Link].

32. Lira CA, Minozzo FC, Sousa BS, et al. Lung function in post-poliomyelitis syndrome: a cross-sectional study. J Bras Pneumol. 2013 Jun-Aug. 39 (4):455-60. [QxMD MEDLINE Link].

33. Söderholm S, Lehtinen A, Valtonen K, Ylinen A. Dysphagia and dysphonia among persons with post-polio syndrome - a challenge in neurorehabilitation. Acta Neurol Scand. 2010 Nov. 122(5):343-9. [QxMD MEDLINE Link].

34. Dean AC, Graham BA, Dalakas M, Sato S. Sleep apnea in patients with postpolio syndrome. Ann Neurol. 1998 May. 43(5):661-4. [QxMD MEDLINE Link].

35. Marin LF, Carvalho LBC, Prado LBF, Oliveira ASB, Prado GF. Restless legs syndrome is highly prevalent in patients with post-polio syndrome. Sleep Med. 2017 Sep. 37:147-50. [QxMD MEDLINE Link].

36. Ring D, Vaccaro AR, Scuderi G, Klein G, Green D, Garfin SR. An association between the flat back and postpolio syndromes: a report of three cases. Arch Phys Med Rehabil. 1997 Mar. 78(3):324-6. [QxMD MEDLINE Link].

37. Chang KH, Lai CH, Chen SC, Hsiao WT, Liou TH, Lee CM. Body composition assessment in taiwanese individuals with poliomyelitis. Arch Phys Med Rehabil. 2011 Jul. 92(7):1092-7. [QxMD MEDLINE Link].

38. Davidson AC, Auyeung V, Luff R, Holland M, Hodgkiss A, Weinman J. Prolonged benefit in post-polio syndrome from comprehensive rehabilitation: a pilot study. Disabil Rehabil. 2009. 31(4):309-17. [QxMD MEDLINE Link].

39. Curtis A, Lee JS, Kaltsakas G, et al. The value of a post-polio syndrome self-management programme. J Thorac Dis. 2020 Oct. 12 (Suppl 2):S153-62. [QxMD MEDLINE Link]. [Full Text].

40. Koopman FS, Voorn EL, Beelen A, et al. No Reduction of Severe Fatigue in Patients With Postpolio Syndrome by Exercise Therapy or Cognitive Behavioral Therapy: Results of an RCT. Neurorehabil Neural Repair. 2015 Aug 7. [QxMD MEDLINE Link].

41. Bruno RL, Frick NM. Stress and "type A" behavior as precipitants of post-polio sequelae: the Felician/Columbia Survey. Birth Defects Orig Artic Ser. 1987. 23 (4):145-55. [QxMD MEDLINE Link].

42. Skough K, Krossen C, Heiwe S, et al. Effects of resistance training in combination with coenzyme Q10 supplementation in patients with post-polio: a pilot study. J Rehabil Med. 2008 Oct. 40(9):773-5. [QxMD MEDLINE Link].

43. Skough K, Broman L, Borg K. Test-retest reliability of the 6-min walk test in patients with postpolio syndrome. Int J Rehabil Res. 2013 Jun. 36(2):140-5. [QxMD MEDLINE Link].

44. Voorn EL, Koopman FS, Brehm MA, et al. Aerobic Exercise Training in Post-Polio Syndrome: Process Evaluation of a Randomized Controlled Trial. PLoS One. 2016. 11 (7):e0159280. [QxMD MEDLINE Link]. [Full Text].

45. Chan KM, Amirjani N, Sumrain M, Clarke A, Strohschein FJ. Randomized controlled trial of strength training in post-polio patients. Muscle Nerve. 2003 Mar. 27(3):332-8. [QxMD MEDLINE Link].

46. Da Silva CP, Szot CL, deSa N. Whole body vibration on people with sequelae of polio. Physiother Theory Pract. 2019 Jun. 35 (6):554-64. [QxMD MEDLINE Link].

47. Bertelsen M, Broberg S, Madsen E. Outcome of physiotherapy as part of a multidisciplinary rehabilitation in an unselected polio population with one-year follow-up: an uncontrolled study. J Rehabil Med. 2009 Jan. 41(1):85-7. [QxMD MEDLINE Link].

48. Stein DP, Dambrosia JM, Dalakas MC. A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome. Ann N Y Acad Sci. 1995 May 25. 753:296-302. [QxMD MEDLINE Link].

49. Dinsmore S, Dambrosia J, Dalakas MC. A double-blind, placebo-controlled trial of high-dose prednisone for the treatment of post-poliomyelitis syndrome. Ann N Y Acad Sci. 1995 May 25. 753:303-13. [QxMD MEDLINE Link].

50. Vasconcelos OM, Prokhorenko OA, Salajegheh MK, Kelley KF, Livornese K, Olsen CH, et al. Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial. Neurology. 2007 May 15. 68(20):1680-6. [QxMD MEDLINE Link].

51. Chan KM, Strohschein FJ, Rydz D, Allidina A, Shuaib A, Westbury CF. Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients. Muscle Nerve. 2006 Jan. 33(1):138-41. [QxMD MEDLINE Link].

52. Koopman FS, Beelen A, Gilhus NE, de Visser M, Nollet F. Treatment for postpolio syndrome. Cochrane Database Syst Rev. 2015 May 18. CD007818. [QxMD MEDLINE Link].

53. Generali JA, Cada DJ. Pyridostigmine: Postpoliomyelitis Syndrome. Hosp Pharm. 2016 May. 51 (5):367-9. [QxMD MEDLINE Link]. [Full Text].

54. Ostlund G, Broman L, Werhagen L, Borg K. Immunoglobulin treatment in post-polio syndrome: Identification of responders and non-responders. J Rehabil Med. 2015 Sep 3. 47 (8):727-33. [QxMD MEDLINE Link].

55. Bertolasi L, Frasson E, Turri M, Gajofatto A, Bordignon M, Zanolin E, et al. A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. J Neurol Sci. 2013 Jul 15. 330(1-2):94-9. [QxMD MEDLINE Link].

56. Trojan DA, Collet JP, Shapiro S, Jubelt B, Miller RG, Agre JC, et al. A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology. 1999 Oct 12. 53(6):1225-33. [QxMD MEDLINE Link].

57. Gonzalez H, Sunnerhagen KS, Sjoberg I, et al. Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial. Lancet Neurol. 2006 Jun. 5(6):493-500. [QxMD MEDLINE Link].

58. On AY, Oncu J, Uludag B, et al. Effects of lamotrigine on the symptoms and life qualities of patients with post polio syndrome: a randomized, controlled study. NeuroRehabilitation. 2005. 20(4):245-51. [QxMD MEDLINE Link].

Divakara Kedlaya, MBBS Locum Provider, Physical Medicine and Rehabilitation and Pain Management

Divakara Kedlaya, MBBS is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Kat Kolaski, MD Assistant Professor, Departments of Orthopedic Surgery and Pediatrics, Wake Forest University School of Medicine

Kat Kolaski, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Physical Medicine and Rehabilitation

Disclosure: Nothing to disclose.

Stephen Kishner, MD, MHA Clinical Professor, Louisiana State University School of Medicine in New Orleans

Stephen Kishner, MD, MHA is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine

Disclosure: Nothing to disclose.

Martin K Childers, DO, PhD Professor, Department of Neurology, Wake Forest University School of Medicine; Professor, Rehabilitation Program, Institute for Regenerative Medicine, Wake Forest Baptist Medical Center

Martin K Childers, DO, PhD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Congress of Rehabilitation Medicine, American Osteopathic Association, Christian Medical & Dental Society, and Federation of American Societies for Experimental Biology

Disclosure: Allergan pharma Consulting fee Consulting

Gerald J Herbison, MD Professor, Department of Rehabilitation Medicine, Jefferson Medical College, Thomas Jefferson University

Disclosure: Nothing to disclose.

Flor M Muñiz, MD Assistant Professor, Department of Physical Medicine and Rehabilitation, McMaster University, Hamilton, Ontario

Flor M Muñiz, MD is a member of the following medical societies: American Medical Association, Canadian Association of Physical Medicine and Rehabilitation, and Canadian Medical Association

Disclosure: Nothing to disclose.

What would you like to print?

• Print this section
• Print the entire contents of
• Print the entire contents of article